These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8085889)
1. [Antibiotic pharmacokinetic indices and their significance in working out antibacterial therapy regimens and predicting their efficacy]. Navashin SM; Navashin PS Antibiot Khimioter; 1993; 38(10-11):26-34. PubMed ID: 8085889 [TBL] [Abstract][Full Text] [Related]
2. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and the dosage regimen of antimicrobial agents. Powers TE; Powers JD Ann Rech Vet; 1990; 21 Suppl 1():41S-45S. PubMed ID: 2080846 [TBL] [Abstract][Full Text] [Related]
5. Parenteral antibiotic therapy in the treatment of lower respiratory tract infections. Strategies to minimize the development of antibiotic resistance. Cazzola M; Matera MG; Noschese P Pulm Pharmacol Ther; 2000; 13(6):249-56. PubMed ID: 11061979 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance. Schentag JJ J Chemother; 1999 Dec; 11(6):426-39. PubMed ID: 10678784 [TBL] [Abstract][Full Text] [Related]
10. Integrating pharmacokinetics, pharmacodynamics and pharmacogenomics to predict outcomes in antibacterial therapy. Gumbo T Curr Opin Drug Discov Devel; 2008 Jan; 11(1):32-42. PubMed ID: 18175265 [TBL] [Abstract][Full Text] [Related]
11. [Microbial resistance to antibiotics from the clinical viewpoint. Paradoxical therapy failures and the significance of pharmacokinetic-pharmacodynamic interactions in vivo]. Rossi M; Gerber AU Ther Umsch; 2002 Jan; 59(1):11-9. PubMed ID: 11851041 [TBL] [Abstract][Full Text] [Related]
12. Future in vitro and animal studies: development of pharmacokinetic and pharmacodynamic efficacy predictors for tissue-based antibiotics. Nightingale CH Pharmacotherapy; 2005 Dec; 25(12 Pt 2):146S-149S. PubMed ID: 16305285 [TBL] [Abstract][Full Text] [Related]
13. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Liu P; Müller M; Derendorf H Int J Antimicrob Agents; 2002 Apr; 19(4):285-90. PubMed ID: 11978499 [TBL] [Abstract][Full Text] [Related]
14. A proposal of a pharmacokinetic/pharmacodynamic (PK/PD) index map for selecting an optimal PK/PD index from conventional indices (AUC/MIC, Cmax/MIC, and TAM) for antibiotics. Kitamura Y; Yoshida K; Kusama M; Sugiyama Y Drug Metab Pharmacokinet; 2014; 29(6):455-62. PubMed ID: 25008846 [TBL] [Abstract][Full Text] [Related]
15. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection. Frimodt-Møller N Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588 [TBL] [Abstract][Full Text] [Related]